Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Peter Steen, Hansen"'
Autor:
Filip Lyng Lindgren, Sofie Brix Christensen, Søren Lundbye-Christensen, Kristian Kragholm, Arne Johannessen, Peter Karl Jacobsen, Steen Buus Kristiansen, Peter Steen Hansen, Mogens Stig Djurhuus, Uffe Jakob Ortved Gang, Ole Dan Jørgensen, Sam Riahi
Publikováno v:
Lyng Lindgren, F, Brix Christensen, S, Lundbye-Christensen, S, Kragholm, K, Johannessen, A, Jacobsen, P K, Kristiansen, S B, Hansen, P S, Djurhuus, M S, Gang, U J O, Jørgensen, O D & Riahi, S 2022, ' Validation of the national Danish ablation database: a retrospective, registry-based validation study ', Scandinavian Cardiovascular Journal, vol. 56, no. 1, pp. 285-291 . https://doi.org/10.1080/14017431.2022.2099009
Lyng Lindgren, F, Brix Christensen, S, Lundbye-Christensen, S, Kragholm, K, Johannessen, A, Jacobsen, P K, Kristiansen, S B, Hansen, P S, Djurhuus, M S, Gang, U J O, Jørgensen, O D & Riahi, S 2022, ' Validation of the national Danish ablation database : a retrospective, registry-based validation study ', Scandinavian Cardiovascular Journal, vol. 56, no. 1, pp. 285-291 . https://doi.org/10.1080/14017431.2022.2099009
Lyng Lindgren, F, Brix Christensen, S, Lundbye-Christensen, S, Kragholm, K, Johannessen, A, Jacobsen, P K, Kristiansen, S B, Hansen, P S, Djurhuus, M S, Gang, U J O, Jørgensen, O D & Riahi, S 2022, ' Validation of the national Danish ablation database : a retrospective, registry-based validation study ', Scandinavian Cardiovascular Journal, vol. 56, no. 1, pp. 285-291 . https://doi.org/10.1080/14017431.2022.2099009
Aim.To validate the National Danish Ablation Database (NDAD) by investigating to what extent data in NDAD correspond to medical records.Type of study. Non-blinded, registry-based, retrospective, validation study. Material and methods. A sample of pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d6ace533de5b7a98950e7fe02ebecf1
https://vbn.aau.dk/da/publications/941310cc-c843-4ee2-914d-033263087f87
https://vbn.aau.dk/da/publications/941310cc-c843-4ee2-914d-033263087f87
Autor:
Jesper, Nielsen, Kristian Hay, Kragholm, Sofie Brix, Christensen, Arne, Johannessen, Christian, Torp-Pedersen, Steen Buus, Kristiansen, Peter Karl, Jacobsen, Peter Steen, Hansen, Mogens Stig, Djurhus, Christoffer, Polcwiartek, Peter, Søgaard, Anna Margrethe, Thøgersen, Uffe Jakob Ortved, Gang, Ole Dan, Jørgensen, Filip Lyng, Lindgren, Sam, Riahi
Publikováno v:
Journal of Geriatric Cardiology : JGC
OBJECTIVES To investigate complications within 30-days following first-time ablation for atrial fibrillation (AF), including a composite of cardiac tamponade, hematoma requiring intervention, stroke or death, in patients ≥ 75 years of age, compared
Autor:
Sam Riahi, Maria Rodrigo-Domingo, Jens Brock Johansen, Henrik Vadmann, Arne Johannessen, Peter Steen Hansen, Susanne S. Pedersen, Jens Cosedis Nielsen, Steen Pehrson
Publikováno v:
Pacing and Clinical Electrophysiology. 38:1166-1172
Background Catheter ablation for atrial fibrillation (AF) is an important but expensive procedure that is the subject of some debate. Physicians’ attitudes toward catheter ablation may influence promotion and patient acceptance. This is the first s
Autor:
Rodolfo Ventura, Thomas Deneke, Boris A. Hoffmann, Karl-Heinz Kuck, Stephan Willems, Peter Steen Hansen, Markus Zarse, Josef Kautzner, Stefan H. Hohnloser, Roland Richard Tilz
Publikováno v:
Kuck, K-H, Tilz, R R, Deneke, T, Hoffmann, B A, Ventura, R, Hansen, P S, Zarse, M, Hohnloser, S H, Kautzner, J, Willems, S & SMS Investigators 2017, ' Impact of Substrate Modification by Catheter Ablation on Implantable Cardioverter-Defibrillator Interventions in Patients With Unstable Ventricular Arrhythmias and Coronary Artery Disease Results From the Multicenter Randomized Controlled SMS (Substrate Modification Study) ', Circulation: Arrhythmia and Electrophysiology, vol. 10, no. 3, 004422 . https://doi.org/10.1161/CIRCEP.116.004422
Background— The implantable cardioverter–defibrillator (ICD) is the standard therapy to prevent sudden cardiac death in patients with coronary artery disease and unstable ventricular tachyarrhythmias. The prospective multinational SMS (Substrate
Autor:
Håkan Walfridsson, Anders Englund, Jens Cosedis Nielsen, Arne Johannessen, Peter Steen Hansen, Leif Spange Mortensen, Gerhard Hindricks, Juha Hartikainen, Pekka Raatikainen, S. Pehrson
Publikováno v:
Nielsen, J C, Johannessen, A, Raatikainen, P, Hindricks, G, Walfridsson, H, Pehrson, S M, Englund, A, Hartikainen, J, Mortensen, L S, Hansen, P S & MANTRA-PAF Investigators 2016, ' Long-term efficacy of catheter ablation as first-line therapy for paroxysmal atrial fibrillation : 5-year outcome in a randomised clinical trial ', Heart . https://doi.org/10.1136/heartjnl-2016-309781
OBJECTIVE: The Medical ANtiarrhythmic Treatment or Radiofrequency Ablation in Paroxysmal Atrial Fibrillation (MANTRA-PAF) trial compared radiofrequency catheter ablation (RFA) with antiarrhythmic drug therapy (AAD) as first-line treatment for paroxys
Publikováno v:
Danish medical journal. 63(2)
Limited data are available regarding safety of catheter ablation of atrial fibrillation (AF) in patients using novel oral anticoagulants (NOAC) before and after pulmonary vein isolation. We aimed to assess the safety of a simple anticoagulation proto
Autor:
Håkan Walfridsson, Gerhard Hindricks, Arne Johannessen, Leif Spange Mortensen, Anders Kirstein Petersen, Steen Pehrson, Ole Kongstad, Peter Steen Hansen, Juha Hartikainen, Pekka Raatikainen, Jens Cosedis Nielsen, Henrik Almroth, Christian Jons
Publikováno v:
Jons, C, Hansen, P S, Johannessen, A, Hindricks, G, Raatikainen, P, Kongstad, O, Walfridsson, H, Pehrson, S, Almroth, H, Hartikainen, J, Petersen, A K, Mortensen, L S, Nielsen, J C & MANTRA-PAF Investigators 2009, ' The Medical ANtiarrhythmic Treatment or Radiofrequency Ablation in Paroxysmal Atrial Fibrillation (MANTRA-PAF) trial: clinical rationale, study design, and implementation ', Europace, vol. 11, no. 7, pp. 917-23 . https://doi.org/10.1093/europace/eup122
Udgivelsesdato: 2009-Jul AIMS: No large randomized multicentre trial has evaluated the efficacy of radiofrequency ablation (RFA) vs. anti-arrhythmic drug (AAD) therapy as a first-line treatment of paroxysmal atrial fibrillation (AF). METHODS AND RESU
Autor:
Peter Steen Hansen, Ole Faergeman, L. G. Jensen, M. J. Kristensen, Niels Gregersen, L. Lemming, Lars Bolund, Margrethe Kjeldsen, I. C. Klausen, Henrik Jensen
Publikováno v:
Jensen, H K, Hansen, P S, Jensen, L G, Kristensen, M J, Klausen, I C, Kjeldsen, M, Lemming, L, Bolund, L, Gregersen, N & Færgeman, O 1995, ' Complexity of molecular genetics of dyslipidemia in a family highly susceptible to ischemic heart disease ', Clinical Genetics, vol. 48, no. 1, pp. 23-28 . https://doi.org/10.1111/j.1399-0004.1995.tb04049.x
Europe PubMed Central
Europe PubMed Central
In a Danish family highly susceptible to ischemic heart disease, hyperlipidemia did not simply cosegregate with a previously undescribed 10 bp deletion in the LDL receptor gene causing heterozygous familial hypercholesterolemia (FH). This mutation, d
Autor:
Arne Johannessen, Anders Englund, Gerhard Hindricks, Leif Spange Mortensen, Antti Hakalahti, Håkan Walfridsson, Peter Steen Hansen, Steen Pehrson, Juha Hartikainen, Jens Cosedis Nielsen, M.J. Pekka Raatikainen, Ole Kongstad, Paavo Uusimaa
Publikováno v:
Raatikainen, M J P, Hakalahti, A, Uusimaa, P, Nielsen, J C, Johannessen, A, Hindricks, G, Walfridsson, H, Pehrson, S, Englund, A, Hartikainen, J, Kongstad, O, Mortensen, L S, Hansen, P S & MANTRA-PAF Investigators 2015, ' Radiofrequency catheter ablation maintains its efficacy better than antiarrhythmic medication in patients with paroxysmal atrial fibrillation : On-treatment analysis of the randomized controlled MANTRA-PAF trial ', International Journal of Cardiology, vol. 198, pp. 108-114 . https://doi.org/10.1016/j.ijcard.2015.06.160
BACKGROUND: The Medical ANtiarrhythmic Treatment or Radiofrequency Ablation in Paroxysmal Atrial Fibrillation (MANTRA-PAF) is a randomized trial comparing radiofrequency catheter ablation (RFA) to antiarrhythmic drugs (AADs) as first-line treatment o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b294431dca60ef74ca038468636ff16c
https://pure.au.dk/portal/da/publications/radiofrequency-catheter-ablation-maintains-its-efficacy-better-than-antiarrhythmic-medication-in-patients-with-paroxysmal-atrial-fibrillation(f5b5f345-4fd2-48c6-a9b2-fd93c88bd1c2).html
https://pure.au.dk/portal/da/publications/radiofrequency-catheter-ablation-maintains-its-efficacy-better-than-antiarrhythmic-medication-in-patients-with-paroxysmal-atrial-fibrillation(f5b5f345-4fd2-48c6-a9b2-fd93c88bd1c2).html
Autor:
Henrik, Vadmann, Susanne S, Pedersen, Jens Cosedis, Nielsen, Maria, Rodrigo-Domingo, Steen, Pehrson, Arne, Johannessen, Peter Steen, Hansen, Jens Brock, Johansen, Sam, Riahi
Publikováno v:
Pacing and clinical electrophysiology : PACE. 38(10)
Catheter ablation for atrial fibrillation (AF) is an important but expensive procedure that is the subject of some debate. Physicians' attitudes toward catheter ablation may influence promotion and patient acceptance. This is the first study to exami